BAX
Baxter International Inc. (NYSE)
Delayed quote data
12/19/2014 04:02 PM
hide quote detailed quote options chain chart help
Last:
74.48
Change:
arrow +0.41
Open:
74.07
High:
74.77
Low:
73.37
Volume:
3,466,979
Percent Change:
+0.55%
Yield:
2.79%
P/E Ratio:
21.6549
52 Week Range:
66.34 to 77.31
After Hours Trading
12/19/2014 06:51 PM
Last:
74.479
Change:
arrow -0.001
Volume:
250,576
10:47 AM ET

Headlines for Baxter International Inc. (NYSE:BAX)

News for Baxter International Inc.

  1. Thursday, October 16, 2014

    1. 07:44 AM ET

      Baxter profit down, but tops expectations MarketWatch

    2. 07:35 AM ET

      Baxter’s Medical-Products Sales Rise The Wall Street Journal Interactive Edition

  2. Tuesday, September 30, 2014

    1. 07:30 PM ET

      Bosses More Flexible About Relocation The Wall Street Journal Interactive Edition

  3. Wednesday, September 24, 2014

    1. 07:54 AM ET

      Merrimack Pharma shares surge on licensing pact with Baxter MarketWatch

    2. 07:43 AM ET

      Baxter, Merrimack to Collaborate on Pancreatic Cancer Drug The Wall Street Journal Interactive Edition

  4. Monday, August 18, 2014

    1. 04:50 PM ET

      Risks Create Tumult for Tech, Health-Care Firms The Wall Street Journal Interactive Edition

  5. Tuesday, August 12, 2014

    1. 10:42 PM ET

      CSL Weighs New Stock Buyback The Wall Street Journal Interactive Edition

    2. 07:35 PM ET

      Australia's CSL considers bigger stock buyback MarketWatch

  6. Wednesday, July 30, 2014

    1. 08:33 AM ET

      Pfizer to buy Baxter’s vaccines for $635 million MarketWatch

    2. 08:19 AM ET

      Pfizer To Buy Baxter's Vaccines The Wall Street Journal Interactive Edition

More

Company Releases for Baxter International Inc.

  1. Thursday, December 18, 2014

    1. 03:15 PM ET

      Baxter to Present at 33rd Annual J.P. Morgan Healthcare Conference BusinessWire - BZX

  2. Wednesday, December 17, 2014

    1. 04:15 PM ET

      Baxter International Fourth Quarter 2014 Financial Results Conference Call BusinessWire - BZX

  3. Monday, December 15, 2014

    1. 09:01 AM ET

      Baxter to Divest Vero Cell Vaccines Platform to Nanotherapeutics BusinessWire - BZX

  4. Wednesday, December 10, 2014

    1. 05:15 PM ET

      Baxter Announces Filing of Form 10 Registration Statement in Connection with Planned Spin off of Biopharmaceuticals Business BusinessWire - BZX

  5. Tuesday, December 09, 2014

    1. 09:00 AM ET

      Baxter’s Culture of Community Engagement and Inclusion Recognized by Leading Organizations BusinessWire - BZX

  6. Monday, December 08, 2014

    1. 08:30 AM ET

      Pre-Market Review on Health Care Equipment Equities - Medtronic, Second Sight Medical Products, Zeltiq Aesthetics, Baxter Intl., and Covidien PR Newswire - PRF

  7. Thursday, December 04, 2014

    1. 08:00 AM ET

      Video Release -- Preclinical Research Differentiating the Activity of Merrimack's MM-398, Nanoliposomal Irinotecan (nal-IRI), Published in Cancer Research GlobeNewswire

  8. Monday, December 01, 2014

    1. 09:01 AM ET

      Baxter Submits Application for U.S. FDA Approval of BAX 855, Extended Half-Life Recombinant FVIII Based on ADVATE for Hemophilia A BusinessWire - BZX

    2. 08:01 AM ET

      Momenta Pharmaceuticals Announces Acceptance of a Clinical Trial Application in Europe for M923, a Biosimilar Version of Humira(R) GlobeNewswire

    3. 07:30 AM ET

      Pfizer Completes Acquisition of Baxter’s Marketed Vaccines BusinessWire - BZX

More

Most recent headlines